TrialX
Image

Validity Test of Wearable Continuous Blood Pressure Measuring System

Validity Test of Wearable Continuous Blood Pressure Measuring System

Recruiting
18 years and older
All
Phase N/A

Overview

  1. Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor.
  2. Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
  3. Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
  4. Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
  5. Criteria of Participant Inclusion
    1. Adult patient in surgical intensive care of Severance Hospital
    2. Voluntarily agreed to participate the research and not included to the exclusion criteria
    3. Criteria of Participant Exclusion
    4. Patient with occlusive peripheral arterial disease
    5. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
    6. Patient administered high-dose of pressor agent over 15 mcg/min
    7. Patient who is not available for measurement of invasive arterial blood pressure
    8. Patient who is not available to wear an wearable device on the wrist
    9. Pregnant woman, minor
    10. Evaluation Parameter
    11. Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
    12. Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
    13. Data Analysis and Statistical Methods
    14. From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
    15. For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
    16. In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.

Description

  1. Recruit participants.
  2. Explain the research purpose and details, and then have the participant sign the consent form.
  3. Before starting the measurement, gather the participant's information such as age, length, and weight.
  4. Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
  5. Wear the wearable device on the opposite wrist from the catheter-inserted.
  6. For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
  7. For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.

Eligibility

Inclusion Criteria:

  1. Adult patient in surgical intensive care of Severance Hospital
  2. Voluntarily agreed to participate the research and not included to the exclusion criteria

Exclusion Criteria:

  1. Patient with occlusive peripheral arterial disease
  2. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
  3. Patient administered high-dose of pressor agent over 15 mcg/min
  4. Patient who is not available for measurement of invasive arterial blood pressure
  5. Patient who is not available to wear an wearable device on the wrist
  6. Pregnant woman, minor

Study details
    Patients in Surgical Intensive Care

NCT04261062

Yonsei University

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.